Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. - Wikidata - wikimedia - TriplyDB

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

http://www.wikidata.org/entity/Q37667474

about

Epigenetic Modulators of Monocytic Function: Implication for Steady State and Disease in the CNS A-to-I editing of coding and non-coding RNAs by ADARs ADAR1, inosine and the immune sensing system: distinguishing self from non-self Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications RNA2DNAlign: nucleotide resolution allele asymmetries through quantitative assessment of RNA and DNA paired sequencing data RES-Scanner: a software package for genome-wide identification of RNA-editing sites.Single-cell RNA sequencing reveals dynamic changes in A-to-I RNA editome during early human embryogenesis.Sequence variation between 462 human individuals fine-tunes functional sites of RNA processing Characterization of RNA editome in primary and metastatic lung adenocarcinomas.A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.Gene regulation in the immune system by long noncoding RNAs.RNA editing is induced by type I interferon in esophageal squamous cell carcinoma.ADAR RNA editing below the backbone.Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.A to I editing in disease is not fake news.RNA editing-dependent epitranscriptome diversity in cancer stem cells.RNA editing generates cellular subsets with diverse sequence within populations.ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.ADAR RNA editing in human disease; more to it than meets the I.CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.RNA Editing Dynamically Rewrites the Cancer Code.Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK.Structure-mediated modulation of mRNA abundance by A-to-I editing.SPRINT: an SNP-free toolkit for identifying RNA editing sites.Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma.A survey on cellular RNA editing activity in response to Candida albicans infections.RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers.RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.2015: Signaling Breakthroughs of the Year.Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.The role of A-to-I RNA editing in cancer development.Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.Methods for the Detection of Adenosine-to-Inosine Editing Events in Cellular RNA.Epitranscriptomics of cancer.RNA editing derived epitopes function as cancer antigens to elicit immune responses

P2860

Q26772718-745DAA5D-C722-45BE-9423-511EBEBA59E0 Q26773402-4D366F90-2BDD-4340-BC42-CB66787188F3 Q26773989-5F456684-C21D-4AC0-B1F9-7110C370B26F Q28078569-F8F132B4-1797-4B6E-980B-560E28E9C8CE Q28586795-13D25D0D-C1BF-4D7B-9A85-94E7BFECF989 Q36107312-274F1D14-2B55-458C-AEC8-BC666127C8A1 Q36149292-57A86497-D1CF-4AB9-B575-B1FEC19F0FA7 Q37248390-60F24917-8E6D-4D72-AD8E-865C56CDF8A8 Q37706941-525DAFFC-3D3A-4427-A3E9-4C8E88F17CBC Q38289096-C886AF69-2402-4759-AE60-AA6C4E37EF52 Q38638798-3E898229-E812-4A8A-BF23-ACE303B7A9CB Q38697151-CB8C7FE4-1437-4FC0-95D7-4A11523D7670 Q38755513-973C9D8C-CE8F-4268-A35D-6F80A023B617 Q38836169-80E3C869-CDCD-4437-BD15-7372FC4067C6 Q39202138-66D9D2E9-9F4A-4342-822A-2F96C433FC63 Q39247132-C67ACB05-1484-4761-A2BA-B7ABFB9A1CBA Q39600191-881DCD19-AED7-4A72-8A11-2BBB5DAE1535 Q39689950-2297F74D-86F0-4FF5-8038-64087EAC358E Q40039590-C36796A4-ED21-42F8-96CC-C864890E7AB9 Q41041403-48538A63-4639-45E3-A1F5-796B0D04C5AF Q41227452-062121BF-0044-4FB1-ABD5-A079F4E2C714 Q41459821-A916C6AC-317F-4342-829F-43A781C1FB7C Q42374136-3F57CD96-64B4-4633-A2AC-8645914774C9 Q42516683-62E2E081-7344-4678-8C96-7DCDA144CBAA Q45067787-78D0C4B6-F800-4423-ADF9-0DDC1A4DC339 Q46212625-F059F1B9-72CC-419D-8E35-52DCB97D6688 Q46284285-E73190E2-EAE6-41A9-9BE9-E72D20897398 Q47174263-4DCA80E7-5A69-43DC-B79A-595B12672AC9 Q47252687-57B9351D-F6C9-4D31-BE56-08040D0ED128 Q47259897-D978D650-7219-4FEA-A388-B84E0AD6BF7A Q47549427-A54A1A16-BDA6-47CA-9648-584D851E9DB0 Q47789946-45F948C9-D5F5-4D5D-B7BC-B37DCDCDD1FD Q47917018-DDE82155-DF55-4985-A7FC-FBC61FA2C3F3 Q47942280-DB4C7C2B-AFF6-4A01-856D-42E48492A511 Q49808366-3E58D636-7CAB-4FA8-BAE6-C508A738F8E1 Q50060481-090A90CF-0F5F-4781-BC03-A8026AB5145B Q50209147-D27562CE-8F6B-4C29-9534-A8BCAF919E6A Q50431197-3942747A-139C-4198-9F65-4739D74C0758 Q55080781-2CA5B642-E998-4F4A-A3A6-44F9BD818461 Q58698657-34A3961D-FD11-4CE6-BA27-D7099B044BE0

P2860

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

http://www.wikidata.org/entity/Q37667474

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 September 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@en

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@nl

type

label

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@en

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@nl

prefLabel

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@en

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

@nl

P1433

Q37667474-EF809182-A800-43FF-8186-69651D90792F

P1476

Q37667474-309A420E-31D9-439B-BE58-6BC364769242

P2093

Q37667474-0ADEA79B-E433-48C8-8C16-C8B8FC4516BE

Q37667474-0DDF8502-2A3E-4FD6-833D-4D1526EDDFA1

Q37667474-13B510BB-9C4E-46A8-87E9-F258F5C2BDC0

Q37667474-17D1B71D-A855-4AB0-BDFE-2C635F7753A6

Q37667474-2CE34409-924B-4AA2-8512-6CED59C972DD

Q37667474-3F07218C-611B-4F9F-91EC-C91E4C35CAE1

Q37667474-454B1E86-EA24-4D5E-B05E-240A4D0D40D0

Q37667474-5134C686-AED5-4C51-82C8-520AB36405DD

Q37667474-5CDE7A20-361A-4040-B14E-D4186C4966AE

Q37667474-7437725B-E08B-4FB7-A067-7B98B1721B0E

P2860

Q37667474-0312F334-4086-4358-AD08-6E0354D18773

Q37667474-04991FB6-8028-4BEE-88DC-E0E078EA340B

Q37667474-08BF9A45-CEA3-4886-B97C-6E72A523940E

Q37667474-0B45618B-C2C1-478D-9EA2-BC985259CCBB

Q37667474-0B7314F9-8829-41E3-AED6-73131A056C8D

Q37667474-0CCFEA3D-9857-410A-A715-D97B1927BCFC

Q37667474-11BF8F65-A60D-4885-85B8-49293116E564

Q37667474-176E96B6-AB5B-4D55-B89B-006115068C15

Q37667474-1ACC10E5-867D-452B-8AA0-D98B6D419AFD

Q37667474-2120132C-837A-4D8A-AEBB-59660789DCDE

P304

Q37667474-9284CC55-DA47-4FCC-A7CC-8538F96DBD14

P31

Q37667474-DE8000D4-AC07-43E6-A213-F5FD295402FF

P356

Q37667474-C531B500-0ACB-40B7-A551-C9015CF22243

P433

Q37667474-3CA8983B-CE0C-4A4D-8CF7-BAE317C45AD6

P478

Q37667474-716B281F-C7E8-480E-9E11-BAF2D8CF9C31

P50

Q37667474-48DCEF0C-9156-4653-B1A4-F517C7314B17

Q37667474-A3F8B8F1-B57F-47FB-84AF-0DE3BFB33665

P577

Q37667474-8AE310D1-554A-4DA3-BC15-CC2522663053

P698

Q37667474-C2673913-D389-4FBA-B12E-4619FC5B1AA7

P921

Q37667474-0BD7F5DA-D435-4D7B-A3B3-70BBCDBC3105

P932

Q37667474-F296D49C-F06B-4E17-8263-8813BB126A78

P356

J.CELREP.2015.09.032

P1433

P1476

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome

@en

P2093

Adam Shlien

http://www.w3.org/2001/XMLSchema#string

Anne Lefort

http://www.w3.org/2001/XMLSchema#string

Christos Sotiriou

http://www.w3.org/2001/XMLSchema#string

David Gacquer

http://www.w3.org/2001/XMLSchema#string

Debora Fumagalli

http://www.w3.org/2001/XMLSchema#string

Denis Larsimont

http://www.w3.org/2001/XMLSchema#string

Françoise Rothé

http://www.w3.org/2001/XMLSchema#string

Frederick Libert

http://www.w3.org/2001/XMLSchema#string

Karen Willard-Gallo

http://www.w3.org/2001/XMLSchema#string

Kornelia Polyak

http://www.w3.org/2001/XMLSchema#string

P2860

A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains

Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation

Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase

ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing

Underediting of glutamate receptor GluR-B mRNA in malignant gliomas

Modulation of microRNA processing and expression through RNA editing by ADAR deaminases

Mutational processes molding the genomes of 21 breast cancers

A diverse range of gene products are effectors of the type I interferon antiviral response

RNA editing by adenosine deaminases that act on RNA

Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome

P304

277-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELREP.2015.09.032

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Christine Desmedt

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26440892

http://www.w3.org/2001/XMLSchema#string

P921

P932

5326813

http://www.w3.org/2001/XMLSchema#string